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osting by EAbstract Trachoma remains the leading cause of preventable corneal blindness in developing
countries. The disease is contracted in early childhood by repeated infection of the ocular surface
by C. trachomatis. Initial clinical manifestation is a follicular conjunctivitis which if not treated
on timely basis, may lead to conjunctival and eyelid scarring that may eventually result in corneal
scarring and loss of vision. Over the past two decades, a remarkable reduction in the prevalence of
active trachoma has occurred due to the World Health Organization’s (WHOs) program GET 2020
for the elimination of trachoma with adoption of the SAFE strategy incorporating Surgery, Anti-
biotic treatment, Facial cleanliness and Environmental hygiene. However, patients who already had
infection at young age may present with adnexal-related complications of trachomatous scarring
that may cause corneal scarring and visual loss. These patients may present with evidence of trichi-
asis/entropion as well as eyelid retraction. Lacrimal complications may include nasolacrimal-duct
obstruction, dacryocystitis and canaliculitis requiring intervention. In addition to the increased risk
for corneal scarring, trichiasis/entropion may further increase the risks for microbial keratitis in
patients who may have unrecognized dacryocystitis and canaliculitis. Female patients may have
more trachomtous-related complications and may present at an early age. Available evidence indi-
cates that SAFE strategy may be effective and on the right track towards achieving GET 2020 goal
for the eradication of trachoma.
ª 2009 King Saud University. All rights reserved.6 1 4821908.
ity. All rights reserved. Peer-
d University.
lsevier
16 I.A. ChaudhryContents
1. Scope of the problem. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2. Risk factors for C. trachomatis infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
3. Mechanism of scarring. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
4. Mechanism of vision loss in trachoma. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
5. Mechanism of nasolacrimal system damage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
6. Treatment: medical and surgical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201. Scope of the problem
Trachoma is the most common infectious cause of blindness
worldwide. It afﬂicts some of the poorest regions of the globe,
predominantly in Africa and Asia (Al-Rifai, 1988; Solomon
and Mabey, 2007). The disease is initiated in early childhood
by repeated infection of the ocular surface byChlamydiatracho-
matis, an intracellular gram-negative bacterium (Burton, 2007).
During acute infection, the disease may remain asymptomatic
but some patients may complain of eye redness, irritation and
discharge (Burton, 2007). The principal initial clinical manifes-
tation is a follicular conjunctivitis. A population based survey
of trachoma and blindness from a rural Nile Delta hamlet, a
trachoma hyper-endemic region found that active trachoma
was common among pre-school children (Courtright et al.,
1989). Among inhabitants 25 years or older, 90% had substan-
tial conjunctival scarring. Severe conjunctival scarring was
common among women (84%) than men (58%), and three-
quarters of older women had trichiasis/entropion compared
with 57% of older men. Blindness was associated with old
age; 17% of residents aged 50 and over had signiﬁcant blind-
ness (Courtright et al., 1989). Trachoma is one of the main
cause of preventable blindness in Saudi Arabia (Tabbara and
Ross-Degnan, 1986; Tabbara and Al-Omar, 1997; Tabbara,
2001). Early surveys during 1955–70 in Eastern Province
revealed prevalence rate of trachoma as 100% in Al Hasa,
98% in Qatif Oasis and 93% in Qatif town dwellers (Murray
et al., 1960; Nichols et al., 1966, 1967, 1969; McComb and Nic-
hols, 1969, 1970; Bobb andNichols, 1969; Bell et al., 1970). Pre-
liminary study by Ministry of Health, Eastern Province in 1986
revealed 3.74% of the population had blindness among them
10.1% due to trachoma (Tabbara and Al-Omar, 1997). In
1986, Ministry of Health established Regional Prevention of
Blindness and Ophthalmic Medical Education Committee,
Eastern Province with six sub-divisions in Al Hasa, Qatif,
Dammam, Al Khobar/Dhahran, Jubail and Hafr Al Batin.
The whole health care was divided in primary, secondary and
tertiary level in 1987 and incorporated primary eye health care
with primary health care. The Trachoma Center was started in
Al Hasa in 1987 and a mass trachoma eradication program was
launched in 1988. Improvement in socio-economic status and
structured health care system over the following 10 years leads
to public awareness, prevention and treatment of bulk of active
trachoma in this region (Tabbara and Al-Omar, 1997). More
recently, provision of comprehensive eye care by completing
preliminary tertiary level care Eye Hospital in Dhahran has fur-
ther reduced the incidence of active trachoma below 0.5%. In
1984, evidence of trachoma (active and inactive) was found
among 22.2% of the Saudi population; 6.2% of them had evi-dence of active trachoma. In addition, 17.4% had conjunctival
scarring as a result of old trachoma, and 1.5% had entropion or
trichiasis. In 1994, clinical evidence of trachoma (active and
inactive) was found among 10.7% of the Saudi population
while 2.6% had active trachoma. Conjunctival scarring as a re-
sult of healed trachoma was seen in 8.1% and 0.2% had trichi-
asis and entropion (Tabbara and Al-Omar, 1997).
2. Risk factors for C. trachomatis infection
Trachoma prevalence is disproportionately high among wo-
men and children in poor rural communities. In particular, risk
factors include lack of facial cleanliness, poor access to water
supplies, lack of latrines, and a large number of ﬂies. House-
hold overcrowding, and the lack of clean water are factors that
predispose to the transmission of the disease (Barenfanger,
1975). In one of the study that compared trends in the preva-
lence of active inﬂammatory trachoma among children under
10 years of age in Marakissa (a small rural village in the Gam-
bia) between the results of eye examinations conducted in
1959, 1987, and 1996, the prevalence of active trachoma infec-
tion dropped from 65.7 cases per 100 in 1959 to 2.4 per 100 in
1996 (Dolin et al., 1997). Declines were also recorded among
children 10–19 years old (from 52.5 to 1.4/100) and among
those 20 years and older (from 36.7 to 0 cases/100). This
dramatic fall, which occurred without any speciﬁc trachoma
control programs in the area, was attributed to both
improvements in socio-economic standards and the training
of village health workers and traditional birth attendants in
eye care (Dolin et al., 1997). Another study of trachoma con-
trol in Burma over a 30-years period also found a remarkable
decline in trachomatous blindness (Evans et al., 1996). An epi-
demiological study of trachoma in Central Tanzania, found
that active inﬂammatory disease peaked in pre-school children,
with 60% showing signs of trachoma (West et al., 1991). Evi-
dence of past infection, scarring, trichiasis, and corneal opac-
ity, rose with age. In this population, 8% of those over age
55 had trichiasis/entropion. Females of all ages had more tra-
choma than males, with a fourfold increased risk of trichiasis
observed in females. Women who were taking care of children
appeared to have more active disease than non-caretakers. Evi-
dence of clustering of trachoma by village, and within village,
by neighbor-hood was also found. Clustering persisted even
after accounting for differences in distance to water, local
religion, and proportion of children with unclean faces.
These ﬁndings may have important implications for a tra-
choma control strategy (West et al., 1991). Trachoma remains
a public health issue in Central Australia. Landers et al. (2005),
found that although the prevalence of the cicatricial and
Figure 1 A 75-years-old-male patient with history of severe
complications of trachoma in the form of eyelid retraction,
trichiasis/entropion and severe dry eye syndrome.
Figure 2 An 85-years-old male patient with long standing
history of eyelid trichiasis/entropion and associated corneal
scarring presented with inability to open his eyes. Surgical
correction in the form of entropion repair resulted in patient’s
ability to open his eyes.
Figure 3 A 60-years-old male with bilateral upper eyelid
retraction (A) due to tarsal/conjunctival contraction and corneal
scarring as Herbert’s pits (B and C), characteristic of trachoma.
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aged 40 years or greater, it still remained a signiﬁcant health
issue in an indigenous population within Central Australia
when compared with other areas of Australia.
Presence of distichiasis and/or dysplastic eyelashes in tra-
chomatous trichiasis cases warrants further analytical studies
to conﬁrm the observation and establish any causal association
(Khandekar et al., 2004). In a prospective evaluation of the
prevalence of distichiasis and/or dysplastic eyelashes among
trachomatous trichiasis cases at the oculoplasty unit of a hos-
pital in Oman over 3 months period, among 80 cases, 58
(72.5%) had abnormal eyelashes in addition to trachomatous
trichiasis (Khandekar et al., 2004). Dysplastic and distichiasis
eyelashes were signiﬁcantly more prevalent in trachomatous
trichiasis cases aged <50 years and those with entropion.
Severe trichiasis reﬂects the magnitude of the trachoma prob-
lem in areas such as Ethiopia. Visual impairment due to trichi-
asis may be highly associated with disease severity and
duration (Figs. 1 and 2). Among the 1635 individuals with
trichiasis presenting for surgery in the Wolayta Zone of
Ethiopia, 82% had bilateral trichiasis and 91% of them re-
ported trichiasis duration of >2 years (Melese et al., 2005).Epilation was practised by over three fourths of the study sub-
jects. A high proportion of patients tested positive for ocular
C. trachomatis at presentation; among them 17% had monoc-
ular blindness and 8% had blindness in their both eyes.
Corneal opacity was highly associated with the trichiasis dura-
tion, severity and visual loss (Melese et al., 2005).
3. Mechanism of scarring
Trachoma appears to initiate a vicious cycle of mucus deﬁ-
ciency, chronic conjunctival inﬂammation and conjunctival
scarring (Blodi et al., 1988). The basic mechanisms involved
in tissue damage and scarring following C. trachomatis remain
to be elucidated (Fig. 3). In specimens taken from patients
with active trachoma, the inﬂammatory inﬁltrate is organized
as lymphoid follicles in the underlying stroma and impression
cytology shows cytoplasmic elementary bodies. Immunohisto-
chemical studies of conjunctival biopsies from children with
active trachoma demonstrate the presence of both humoral
and cell-mediated immune responses (Abu el-Asrar et al.,
2001). In the active trachomatous conjunctivitis, macrophages
may play an active role in conjunctival scarring by up-regulat-
ing local production of extracellular matrix by the expression
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factor (Abu El-Asrar et al., 2006). In the chronic phase,
inﬂammation causes scarring of the conjunctiva followed by
dry eye which can result in blindness. Trachoma may cause
dryness of the eye by decreased mucus production and aque-
ous secretions (Fig. 1). Light microscopy may show subepi-
thelial ﬁbrosis, membranes formation, squamous metaplasia,
loss of goblet cells, pseudogland formation, degeneration of
orbicularis oculi muscle ﬁbres, subepithelial vascular dilata-
tion, localized perivascular amyloidosis and subepithelial lym-
phocytic inﬁltration. Conjunctival impression cytology may
reveal signiﬁcant reduction of goblet cell population among
these patients. Accessory lacrimal glands and ducts may be
compromised by subepithelial inﬁltration and scarring. The
contraction of the subepithelial ﬁbrous tissue formed by col-
lagen ﬁbers and anterior surface drying are the main factors
contributing to the chronic cicatrization and entropion forma-
tion (Guzey et al., 2000). Severe cases of trachoma may lead
to contracture of the conjunctiva and deeper tissues including
Mu¨ller muscle and the tarsal plate. Hence, the upper eyelids
of these patients may show eyelid retraction that also may
show as eyelid lag on patient’s down-gaze (Alsuhaibani and
Al-Fakey, 2007).
4. Mechanism of vision loss in trachoma
Repeated eye infection with C. trachomatis organism may trig-
ger recurrent chronic inﬂammatory episodes leading to the
development of conjunctival scarring. This scar tissue con-
tracts, distorting the eyelids (entropion) causing contact be-
tween the eyelashes and the surface of the eye (trichiasis)
compromising the cornea with blinding opaciﬁcation (Tabbara,
2001). Trichiasis/entropion may be the most common single
factor leading to the signiﬁcant blinding complication. Infact,
entropion may be the most signiﬁcant predictor of corneal
opacity (Figs. 1, 2 and 4). Eyelids of patients with inactive tra-
choma may be thickened. This thickening could be attributed
to trachomatous changes in the conjunctiva and tarsus. Light
microscopy studies of tarsal plates and palpebral conjunctivae
obtained from the upper eyelids of patients having inactive
trachoma show a thick and compact subepithelial ﬁbrous mem-Figure 4 A 68-years-old female with severe trichiasis/entropion
and corneal scarring requiring penetrating keratoplasty for her
right eye. She had previous multiple hyfercations and entropion
repair of her right upper eyelid resulting in loss of anterior eyelid.brane adherent to the tarsal plate (Al-Rajhi et al., 1993). Other
histopathologic ﬁndings include atrophy of the meibomian
glands with thickening of the acinar basement membrane, loss
of goblet cells, retention cysts, and hyaline degeneration of the
tarsal plate with focal replacement by adipose tissue (Al-Rajhi
et al., 1993). Chronic trichiasis and eyelid entropion can result
in signiﬁcant corneal scarring and associated visual loss. In a
retrospective study of 137 patients from Senegal who under-
went 199 surgical procedures, over 51% of them already had
some kind of corneal complications due to abnormalities of
their eyelid conditions. The average age of these patients was
49 years with a higher percentage of women (Ndoye et al.,
1997). Entropion is the most signiﬁcant predictor of corneal
opacity. Cross sectional associations suggest that epilation
may not be helpful for eyes with mild entropion, but may offer
protection against corneal opacity in eyes with moderate to se-
vere entropion. Epilation may not be a substitute for trichiasis
surgery, as 43% of eyes with severe entropion that have epila-
tion performed may still have corneal opacities (West et al.,
2006). Marginal rotation by a posterior approach is an effective
and simple procedure with fewer complications, even when per-
formed by non-ophthalmologists. A study from the indigenous
population from the Upper Rio Negro basin of Brazil, on 73
upper eyelids of 46 Indians (35 females, 11 males) with cicatri-
cial upper eyelid trichiasis/entropion requiring surgery which
had been performed by non-ophthalmologist physician who
had general surgery experience with an extremely short period
(one week) of ophthalmic training has been reported (Soares
and Cruz, 2004). The surgery was performed by using a mar-
ginal rotational procedure by a posterior approach. Reevalua-
tion 6 months after surgery revealed that 56 eyelids (76.7%)
were free from trichiasis, whereas residual trichiasis was ob-
served in 17 eyelids (23.3%) of 10 subjects. In these cases, trichi-
asis was either lateral or medial to the central portion of the lid.
Of these 10 patients, only four reported that the surgery did not
improve the irritative symptoms (Soares and Cruz, 2004).
Surgery for entropion may result in healing of superﬁcial
keratopathy and improve tear ﬁlm stability. The realigned eye-
lid margin may spread tears evenly and efﬁciently, contributing
to improved vision. These changes may take place over 1–90
days and should be considered when contemplating keratopl-
asty, intraocular or keratorefractive procedures after
entropion correction (Monga et al., 2008). Patients with tra-
chomatous trichiasis/entropion suffer in the physical, psycho-
logical and environmental domains of health-related quality
of life even when vision is normal. Timely intervention is essen-
tial not only to prevent corneal blindness but also to reduce the
suffering caused by the non-visual symptoms. In one prospec-
tive, case-controlled, interventional study, health-related qual-
ity of life among the 60 patients with trachomatous trichiasis/
entropion was found to be improved after intervention
(Dhaliwal et al., 2006). Cornea grafting may be necessary in
patients who have signiﬁcant corneal opacity despite correc-
tion of trichiasis/entropion (Fig. 4). A recent study from King
Khaled Eye Specialist Hospital, treating 127 patients with
trachomatous corneal scarring undergoing penetrating kera-
toplasty revealed that the procedure had a good prognosis
for graft survival in over 80% of patients over a 4-year
period (Al-Fawaz and Wagoner, 2008). Patients with mild or
well-controlled ocular surface disease and absent or previously
surgically corrected eyelid abnormalities had the best visual
outcome.
Figure 5 A 68-years-old diabetic patient had recurrent episodes
of left-sided microbial keratitis and failed penetrating keratoplas-
ty; which were attributed to untreated chronic dacryocystitis.
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Trachomatous scarring can also affect nasolacrimal system
drainage (Figs. 5 and 6). A clinical study of the lacrimal com-
plications of trachoma from an eastern province of Saudi Ara-
bia revealed that among the 579 Saudi Arabian patients
examined, 446 (77%) showed clinical evidence of trachoma,
62 of whom had severe inactive trachoma (Tabbara and Bobb,
1980). From this group the following lacrimal complications
were observed: dry eye syndrome, punctal phimosis, punctal
occlusion, canalicular occlusion, nasolacrimal-duct obstruc-
tion, dacryocystitis, dacryocystocele, and dacryocutaneous ﬁs-
tula. Histopathologic examination of seven lacrimal-sac
biopsies showed the same cicatrizing changes seen in 14 con-
junctival biopsies (Tabbara and Bobb, 1980). Patients with fol-
licular conjunctivitis caused C. trachomatis infection may
develop canaliculitis, canalicular obstruction, dacryocystitis
and nasolacrimal-duct obstruction. Bacteriological examina-
tion of conjunctival smears in patients with follicular conjunc-
tivitis may show co-infection with other microbial organisms.
It has been suggested that all cases of chronic follicular con-
junctivitis with lacrimal inﬂammation that are resistant to top-Figure 6 A 63-years-old male presented with 1-year history of left up
pressure over the left upper canaliculi resulted in excretions (B).ical antibiotics should suggest the possibility of infection with
C. trachomatis (Janssen et al., 1993). In the patients with a his-
tory old trachomatous scarring, lacrimal-sac biopsies per-
formed during dacryocystohinostomies has revealed loss of
the epithelial lining in the lacrimal sac (Rice and Kersten,
1988). The authors theorized that the common canalicular as
well as nasolacrimal-duct obstructions were presumably sec-
ondary to trachoma. These specimens were negative for Chla-
mydia supporting evidence for clinically inactive disease.
6. Treatment: medical and surgical
Both non-surgical and surgical interventions have been found
to be cost effective means of preventing trachomatous visual
impairment. The World Health Organization (WHO) is lead-
ing a global effort to eliminate Blinding Trachoma, through
the implementation of the SAFE strategy (Bailey and Lietman,
2001). This involves surgery for trichiasis, antibiotics for infec-
tion, facial cleanliness (hygiene promotion) and environmental
improvements to reduce transmission of the organism. With
full implementation, the program promises signiﬁcant reduc-
tion in the spread of acute infection. However, there are signif-
icant gaps in the evidence base and optimal management
remains uncertain (Burton, 2007). Recently, several affective
therapeutic modalities for trachoma have been proven useful.
Azithromycin oral single dose has been found to be safe and
effective in children with active trachoma. Conjunctival biopsy
specimens obtained from patients receiving a single oral dose
of azithromycin show sustained high levels of the drug (above
MIC of Chlamydia) for up to 2 weeks after intake. These pro-
longed high levels of azithromycin in the conjunctival tissue
following a single oral dose make the drug suitable for the
treatment of endemic trachoma (Tabbara, 2001). Biannual
mass distribution of azithromycin may locally eliminate ocular
chlamydial infection from severely affected communities. A
cross-sectional survey of two villages in Africa, previously
enrolled and monitored over 42 months as part of a larger
group randomized clinical trial, six biannual mass treatments
with oral azithromycin resulted in signiﬁcant reduction of clin-
ical active trachoma and laboratory evidence of chlamydial
ribonucleic acid (RNA) (Biebesheimer et al., 2009). Clinical
trachoma activity in children aged 1–5 years decreased from
78% and 83% in the two villages before treatment to 17%per eyelid swelling un-responsive to previous curettage (A). Focal
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infection in the same age group decreased from 48% to 0% in
both villages at 42 months. When all age groups were exam-
ined, there were zero cases with evidence of chlamydial RNA
among 758 total villagers tested (Biebesheimer et al., 2009).
Management of trachomatous cicatricial trichiasis and
entropion of the eyelids presents a difﬁcult problem (Yorston
and Mabey, 2006). Over the years, many surgical approaches
have been developed to address it (Yorston and Mabey,
2006; Cockburn, 1943; Chandra and Taneja, 1964; Sandford-
Smith, 1976; Thommy, 1980; Niederer and Sutter, 1981; Rice
et al., 1989; Teichmann, 1988; Nasr, 1991; Bujger et al.,
2004; Sadiq and Pai, 2005). Although the WHO document
WHO/PBL/93.29 recommends the bilamellar tarsal rotation
operation for trachomatous entropion, Bujger et al. (2004),
has described an operation that has proved to be very reliable.
It is a modiﬁed tarsal wedge resection and the eversion splint-
ing-grey line incision. A possible additional correction of the
grey line incision may improve the results. By this method,
the rate of failed operations, which consisted of incomplete
closure of the lids or more than two inverted lashes remaining,
was 6.9% (Bujger et al., 2004). A modiﬁed version of Wies’s
operation offers the correction of cicatricial entropion in which
the most important modiﬁcation being a different plane for the
incision through the eyelid (Sandford-Smith, 1976). Certain
interventions have been shown to be more effective at eliminat-
ing trichiasis. Most effective surgery, however, is the full-thick-
ness incision of the tarsal plate and rotation of the terminal
tarsal strip 180. Full thickness incision of the tarsal plate
and rotation of the lash-bearing lid margin through 180 is
probably the best technique and is preferable in the community
settings. The use of double-sided sticking plaster is more effec-
tive than epilation as a temporary measure. Surgery may be
carried out by an ophthalmologist or a trained ophthalmic
assistant. The addition of azithromycin treatment at the time
of surgery may not improve the outcome (Yorston andMabey,
2006). A modiﬁed surgical technique combining bilamellar tar-
sal margin rotation procedure with blepharoplasty has been
advocated (Sadiq and Pai, 2005). With this technique, the eye-
lids as well as the normal eyelashes can be rotated away from
the surface of the eye. These eyes may have adequate lid clo-
sure and regular lid margin. This modiﬁed technique prevents
any overhanging baggy fold of skin at operation site. Further,
the modiﬁed technique of combining bilamellar tarsal rotation
procedure with blepharoplasty appears to be an effective surgi-
cal technique in the management of the trachomatous cicatri-
cial entropion of the upper eye lid. It achieves successful
anatomical correction along with more acceptable cosmetic
appearance (Sadiq and Pai, 2005). Isolated cilia posterior to
normal lash line can be treated by hyfercation.
In developing countries, where manpower and other re-
sources are limited and patient-load high, ophthalmic surgeons
should choose a procedure that is simple, quick and effective.
In a prospective study lids with moderate or severe trachoma-
tous entropion were compared for the efﬁcacy of three com-
mon surgical procedures of increasing complexity in the
correction of trachomatous entropion by either terminal tarsal
rotation, tarsal rotation with tarso-conjunctival advancement,
or anterior lamellar repositioning with lid margin split and
wedge resection of tarsus (Dhaliwal et al., 2004). The proce-
dures were compared for improvement of symptoms, duration
of surgery, cosmesis, rate and type of complications, anatom-ical correction, failure and recurrence. Terminal tarsal rota-
tion, the simplest technique took signiﬁcantly less time. The
three procedures were comparable in achieving cosmesis, ana-
tomical correction, and rate of complications. In general, ter-
minal tarsal rotation after transverse tarsotomy should be
the procedure of choice in the correction of moderate or severe
(without lid gap) trachomatous entropion. A lid-splitting pro-
cedure by using a bare-tarsus technique and omitting any
grafting has been recommended by Teichmann (1988), in pa-
tients with trachomatous entropion. Additional radial inci-
sions at the nasal and temporal edges of the anterior lamella
may be advantageous, as the often superimposed blepharo-
spasm can be abolished by the weakening of the tarsal part
of the orbicularis muscle (Teichmann, 1988). Also, there may
be low tendency for the recessed anterior lamella to creep back
down to the lid margin. Cicatricial entropion with hard palate
mucous membrane grafting for both upper and lower eyelid
surgery may offer high symptomatic and anatomical cure
rates. The requirement for further surgical intervention may
be low (Swamy et al., 2008).
In conclusion, by the establishment of the GET 2020 goal,
the WHO has set an ambitious target for country programs.
The currently recommended SAFE strategy targets all key ele-
ments believed to be necessary for a short- and long-term inter-
vention program. Additional research may enhance the
implementation of the SAFE strategy. In the current climate
of signiﬁcant political and social momentum for trachoma
control, the SAFE strategy is a safe bet to accomplish the erad-
ication of blinding trachoma (West, 2003).References
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